Insufficient scRNA-seq data for expression of TRIM15 at single-cell level.
Insufficient scRNA-seq data for expression of TRIM15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 799.27 | 226 / 226 | 85% | 17.82 | 347 / 406 |
intestine | 78% | 879.42 | 755 / 966 | 95% | 41.86 | 502 / 527 |
kidney | 98% | 501.15 | 87 / 89 | 75% | 13.35 | 680 / 901 |
stomach | 16% | 14.77 | 56 / 359 | 95% | 30.18 | 271 / 286 |
pancreas | 17% | 5.84 | 56 / 328 | 83% | 23.38 | 147 / 178 |
skin | 63% | 50.87 | 1132 / 1809 | 0% | 0 | 0 / 472 |
esophagus | 8% | 2.57 | 112 / 1445 | 49% | 17.91 | 90 / 183 |
lung | 17% | 4.20 | 100 / 578 | 19% | 3.78 | 220 / 1155 |
bladder | 0% | 0 | 0 / 21 | 27% | 10.19 | 134 / 504 |
uterus | 2% | 0.51 | 4 / 170 | 21% | 4.23 | 98 / 459 |
peripheral blood | 21% | 5.11 | 198 / 929 | 0% | 0 | 0 / 0 |
spleen | 20% | 4.46 | 48 / 241 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 4% | 0.32 | 18 / 430 |
breast | 2% | 3.60 | 11 / 459 | 1% | 0.06 | 9 / 1118 |
prostate | 2% | 0.40 | 4 / 245 | 0% | 0 | 0 / 502 |
adipose | 1% | 0.45 | 18 / 1204 | 0% | 0 | 0 / 0 |
thymus | 1% | 0.09 | 4 / 653 | 0% | 0.02 | 2 / 605 |
blood vessel | 1% | 0.18 | 11 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.06 | 1 / 258 | 0% | 0 | 0 / 230 |
brain | 0% | 0.07 | 10 / 2642 | 0% | 0 | 0 / 705 |
heart | 0% | 0.05 | 3 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.02 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_1900246 | Biological process | positive regulation of RIG-I signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0007500 | Biological process | mesodermal cell fate determination |
GO_1901253 | Biological process | negative regulation of intracellular transport of viral material |
GO_0044790 | Biological process | suppression of viral release by host |
GO_0005925 | Cellular component | focal adhesion |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0140313 | Molecular function | molecular sequestering activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TRIM15 |
Protein name | Tripartite motif containing 15 (Tripartite motif-containing protein 15) TRIM15 (Tripartite motif-containing protein 15) Tripartite motif-containing protein 15 TRIM15 (Tripartite motif-containing 15) E3 ubiquitin-protein ligase TRIM15 (EC 2.3.2.27) (RING finger protein 93) (Zinc finger protein 178) (Zinc finger protein B7) |
Synonyms | RNF93 ZNF178 ZNFB7 hCG_23773 |
Description | FUNCTION: E3 ubiquitin ligase that plays a role in several processes including innate antiviral immnity, cell migration and chemotaxis . Acts as a 'Lys-63'-specific ubiquitin ligase for MAPK1/ERK2 and MAPK3/ERK1, promoting their activation by facilitating their interaction with MAP2K1 and MAP2K2 . Plays also a role in cell migration and chemotaxis by acting as a stable focal adhesion component upon recruitment by multi-adapter protein paxillin/PXN . Functions in the RIGI-mediated interferon induction pathway upstream or at the level of MAVS . Inhibits NF-kappa-B activation by turnover of 'Lys-63'-linked ubiquitination of MAP3K7/TAK1. Mechanistically, prevents TRIM8 cytoplasmic translocation and thus inhibits TRIM8-mediated 'Lys-63'-linked polyubiquitination of MAP3K7/TAK1 in the cytoplasm . Plays also an important regulatory effect on the activation of hepatic stellate cells (HSCs). . |
Accessions | ENST00000427091.6 [Q9C019-1] ENST00000550969.2 H0Y5R0 ENST00000552836.2 [Q9C019-2] ENST00000619857.4 A0A087X199 ENST00000431059.6 [Q9C019-1] ENST00000423220.5 ENST00000425255.5 ENST00000552062.2 ENST00000421984.6 [Q9C019-1] Q5SRL0 ENST00000424597.5 A0A0G2JL27 ENST00000444157.5 ENST00000548732.2 ENST00000429524.6 ENST00000430090.6 ENST00000552676.2 [Q9C019-2] ENST00000427952.5 A0A0G2JJP1 ENST00000414873.6 [Q9C019-1] ENST00000548653.2 ENST00000550400.2 [Q9C019-2] ENST00000546888.2 ENST00000550694.2 ENST00000550702.2 Q9C019 ENST00000376694.9 [Q9C019-1] ENST00000426765.5 ENST00000433744.1 ENST00000440260.5 ENST00000259930.10 [Q9C019-1] |